Amplexor in Pharmaceutical Technology

Artificial intelligence and machine-learning promise to change the role and business models of life sciences in future, as part of a broader transformation of the health value chain. But where does this leave Big Pharma and the wider Life Sciences industry (which has done well for so long) for providing treatments that alleviate, heal, and manage existing patient conditions? How far might AI take them in transforming the way they operate and, indeed, the role they play in the health cycle?